Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felicitas Thol

Showing results (61-70 of 126) with videos related to

Pageof 13
Sort By:
Blood Advances|September 17, 2021
Clonal expansion of CD8+ T cells reflects graft-versus-leukemia activity and precedes durable remission following DLIChristian R Schultze-Florey, Leonie Kuhlmann, Solaiman Raha, et al.
Blood|March 6, 2012
Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromesFelicitas Thol, Sofia Kade, Carola Schlarmann, et al.
Blood|January 7, 2022
Oral azacitidine prolongs survival of patients with AML in remission independently of measurable residual disease statusGail J Roboz, Farhad Ravandi, Andrew H Wei, et al.
Oncogene|June 2, 2018
Immune checkpoints PVR and PVRL2 are prognostic markers in AML and their blockade represents a new therapeutic optionHauke Stamm, Felix Klingler, Eva-Maria Grossjohann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2011
Prognostic importance of histone methyltransferase MLL5 expression in acute myeloid leukemiaFrederik Damm, Tina Oberacker, Felicitas Thol, et al.
Blood|March 5, 2011
Integrative prognostic risk score in acute myeloid leukemia with normal karyotypeFrederik Damm, Michael Heuser, Michael Morgan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 7, 2015
Expression of Hedgehog Pathway Mediator GLI Represents a Negative Prognostic Marker in Human Acute Myeloid Leukemia and Its Inhibition Exerts Antileukemic EffectsJasmin Wellbrock, Emily Latuske, Julian Köhler, et al.
Blood|March 20, 2023
Impact of TP53 on outcome of patients with myelofibrosis undergoing hematopoietic stem cell transplantationNico Gagelmann, Anita Badbaran, Rachel B Salit, et al.
Leukemia|June 25, 2020
Effective drug treatment identified by in vivo screening in a transplantable patient-derived xenograft model of chronic myelomonocytic leukemiaArnold Kloos, Konstantinos Mintzas, Lina Winckler, et al.
Bone Marrow Transplantation|May 21, 2024
Anti-T-lymphocyte globulin improves GvHD-free and relapse-free survival in myelofibrosis after matched related or unrelated donor transplantationKristin Rathje, Nico Gagelmann, Rachel B Salit, et al.
Pageof 13

Showing results (61-70 of 126) with videos related to

Sort By:
Pageof 13
Blood Advances|September 17, 2021
Clonal expansion of CD8+ T cells reflects graft-versus-leukemia activity and precedes durable remission following DLIChristian R Schultze-Florey, Leonie Kuhlmann, Solaiman Raha, et al.
Blood|March 6, 2012
Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromesFelicitas Thol, Sofia Kade, Carola Schlarmann, et al.
Blood|January 7, 2022
Oral azacitidine prolongs survival of patients with AML in remission independently of measurable residual disease statusGail J Roboz, Farhad Ravandi, Andrew H Wei, et al.
Oncogene|June 2, 2018
Immune checkpoints PVR and PVRL2 are prognostic markers in AML and their blockade represents a new therapeutic optionHauke Stamm, Felix Klingler, Eva-Maria Grossjohann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2011
Prognostic importance of histone methyltransferase MLL5 expression in acute myeloid leukemiaFrederik Damm, Tina Oberacker, Felicitas Thol, et al.
Blood|March 5, 2011
Integrative prognostic risk score in acute myeloid leukemia with normal karyotypeFrederik Damm, Michael Heuser, Michael Morgan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 7, 2015
Expression of Hedgehog Pathway Mediator GLI Represents a Negative Prognostic Marker in Human Acute Myeloid Leukemia and Its Inhibition Exerts Antileukemic EffectsJasmin Wellbrock, Emily Latuske, Julian Köhler, et al.
Blood|March 20, 2023
Impact of TP53 on outcome of patients with myelofibrosis undergoing hematopoietic stem cell transplantationNico Gagelmann, Anita Badbaran, Rachel B Salit, et al.
Leukemia|June 25, 2020
Effective drug treatment identified by in vivo screening in a transplantable patient-derived xenograft model of chronic myelomonocytic leukemiaArnold Kloos, Konstantinos Mintzas, Lina Winckler, et al.
Bone Marrow Transplantation|May 21, 2024
Anti-T-lymphocyte globulin improves GvHD-free and relapse-free survival in myelofibrosis after matched related or unrelated donor transplantationKristin Rathje, Nico Gagelmann, Rachel B Salit, et al.
Pageof 13